Crystalys Therapeutics Raises $130M in Series B Funding

Crystalys Therapeutics raised $130 million in Series B funding. The biotech company focuses on developing small molecule therapies targeting protein-protein interactions. The financing will support advancing its pipeline of drug candidates toward clinical trials.